REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Saisun Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Saisun Pharma Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Saisun Pharma Private Limited is an unlisted company, incorporated on 27/06/2003. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL2003PTC121103 and registration number is 121103. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Property No. 454, F.I.E. First Floor Patparganj Industrial Area,
East Delhi; Delhi; Postal Code: 110092

Contact Details: Purchase the Saisun Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Saisun Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Saisun Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Saisun Pharma Private Limited report to view the information.
Incorporation Date:
June 27, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
99.99%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Saisun Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
24.09%▲
Total operating revenue
24.08%▲
Operating profit (EBIT)
32.55%▲
EBITDA
32.4%▲
Net Profit (Loss) for the Period
34.47%▲
Total assets
-2.28%▼
Total equity
16.89%▲
Operating Profit Margin (ROS)
0.08%▲
Net Profit Margin
0.08%▲
Return on Equity (ROE)
1.89%▲
Debt to Equity Ratio
17.46%▲
Quick Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo